STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon
Launched by UNIVERSITY OF PITTSBURGH · Apr 29, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The STABILITY 2 trial is studying the best ways to perform surgery for young people who have torn their anterior cruciate ligament (ACL), a common injury in athletes. The trial will compare two types of surgical grafts—bone-patellar-tendon-bone (BPTB) and quadriceps tendon (QT)—and whether adding an extra procedure called lateral tenodesis (LET) can help prevent re-injury. The goal is to find the most effective approach to improve recovery and reduce the risk of future knee problems in active patients aged 14 to 25.
To participate in this trial, individuals need to be between 14 and 25 years old, have a knee injury where the ACL is torn, and be physically active in sports that involve quick movements. They should also have specific knee conditions that indicate a higher risk of re-injury. Participants will randomly be assigned to one of the surgery options and will be closely monitored throughout their recovery. This study is important because it aims to improve long-term outcomes for young athletes who are at risk of re-injuring their knees after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 14-25,
- • An ACL-deficient knee,
- • Skeletal maturity (i.e. closed epiphyseal growth plates on standard knee radiographs),
- • At least two of the following: participate in a competitive pivoting sport; have a pivot shift of grade 2 or greater; have generalized ligamentous laxity (Beighton score of ≥4) and/or genu recurvatum \>10 degrees.
- Exclusion Criteria:
- • Previous ACLR on either knee,
- • Partial ACL injury (defined as one bundle ACL tear requiring reconstruction/augmentation of the torn bundle with no surgery required for the intact bundle),
- • Multiple ligament injury (two or more ligaments requiring surgery),
- • Symptomatic articular cartilage defect requiring treatment other than debridement,
- • \>3 degrees of asymmetric varus,
- • Inflammatory arthropathy,
- • Inability to provide consent,
- • Pregnancy at baseline.
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Ann Arbor, Michigan, United States
Minneapolis, Minnesota, United States
New York, New York, United States
San Francisco, California, United States
Toronto, Ontario, Canada
Pittsburgh, Pennsylvania, United States
Minneapolis, Minnesota, United States
Albuquerque, New Mexico, United States
Calgary, Alberta, Canada
Hamilton, Ontario, Canada
London, Ontario, Canada
Aarhus, , Denmark
Winnipeg, Manitoba, Canada
Banff, Alberta, Canada
Aarhus, , Denmark
Coventry, , United Kingdom
Redwood City, California, United States
Ottawa, Ontario, Canada
Lexington, Kentucky, United States
Charlottesville, Virginia, United States
New Westminster, British Columbia, Canada
Oslo, , Norway
Winston Salem, North Carolina, United States
Halifax, Nova Scotia, Canada
Münster, , Germany
Stockholm, , Sweden
Baton Rouge, Louisiana, United States
Bowling Green, Kentucky, United States
Bristol, , United Kingdom
Bristol, , United Kingdom
Cologne, , Germany
Dublin, Dublin 9, Ireland
Orlando, Florida, United States
Dublin, , Ireland
Patients applied
Trial Officials
James J Irrgang, PT PhD FAPTA
Principal Investigator
University of Pittsburgh
Alan Getgood, MD FRCS
Principal Investigator
Fowler Kennedy Sport Medicine Clinic, Western University, Department of Surgery
Volker Musahl, MD
Principal Investigator
University of Pittsburgh
Dianne M Bryant, PhD
Principal Investigator
Western University, School of Physical Therapy & Department of Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials